The Pharmaceutics Laboratory has long expertise in the design and analysis of phase I and bioequivalence studies. The leader of the unit, Professor Konstantinos Avgoustakis, serves as assessor of medicines for human use for the Greek National Medicines Organization (EOF) and as an expert of the European Medicines Agency (EMA). The Unit also specializes on the development of conventional and novel, nanotechnology based, pharmaceutical products.
- Validated software for pharmacokinetics data determination ((Phoenix 64 WinNonlin 7.0 software) and for Statistical analysis of bioequivalence studies (SAS® version 9.4 or later)
- A variety of modern equipment for developing conventional and controlled drug delivery systems is available, including pilot scale tableting machine, lab-scale capsule filling machine, diffusion powder mixer, mini extruder, Freeze-Dryer, Spray-Dryer, jet extrusion printers (Bioprinter, Food Printer), laser printers (stereolithography apparatus, digital light processing), electrospinning, high pressure liquid chromatography (HPLC-DAD, fluorescence, refractive index), fluorescence spectrometer, Dynamic Light Scattering and zeta potential (Malvern Zetasizer ZS), spray particle size analyzer (Malvern Spraytec), surface area & pore size analyzers (ΒΕΤ), mercury porosimetry, dissolution tester, hardness tester for tablets, Franz cells for diffusion studies, Differential Scanning Calorimetry (DSC), Thermal Gravimetric Analysis (TGA), Fourier Transform Infrared (FTIR), Near InfraRed (NIR), viscometer, rheometer, polarized microscope, Transmission Electron Microscopy (TEM), Scanning electron Microscopy (SEM).